General MedicationsINTRAMUSCULAR, SUBCUTANEOUSStandard
ADRENACLICK
EPINEPHRINE
Standard Dose
EQ 0.3MG/DELIVERY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ADRENACLICK is listed in Drugs@FDA under application 020800 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY Sponsor IMPAX Submission history Latest submission status date: 2026-03-19 00:00:00.
Structured Monograph
Clinical summary
Approval overview ADRENACLICK is listed in Drugs@FDA under application 020800 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient EPINEPHRINE Form and strength INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY Sponsor IMPAX Submission history Latest submission status date: 2026-03-19 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.